Recent Finacing
Recent Raise
Seventeen develops an intratumoral injectable biocompatible gel embedded with radioactive particles for localized tumor ablation designed to maximize tumor dose while minimizing collateral tissue exposure.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors